Yazici Y, Hatemi G, Bodaghi B, Cheon JH, Suzuki N, Ambrose N, et al. Behcet syndrome. Nat Rev Dis Primers. 2021;7(1):67.

Article  PubMed  Google Scholar 

Costagliola G, Cappelli S, Consolini R. Behçet's disease in children: diagnostic and management challenges. Ther Clin Risk Manag. 2020;16:495–507.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Batu ED. Diagnostic/classification criteria in pediatric Behcet’s disease. Rheumatol Int. 2019;39(1):37–46.

Article  PubMed  Google Scholar 

Ozen S. Pediatric onset Behcet disease. Curr Opin Rheumatol. 2010;22(5):585–9.

Article  PubMed  Google Scholar 

Butbul Aviel Y, Batu ED, Sozeri B, Aktay Ayaz N, Baba L, Amarilyo G, et al. Characteristics of pediatric Behcet’s disease in Turkey and Israel: a cross-sectional cohort comparison. Semin Arthritis Rheum. 2020;50(3):515–20.

Article  CAS  PubMed  Google Scholar 

Karincaoglu Y, Borlu M, Toker SC, Akman A, Onder M, Gunasti S, et al. Demographic and clinical properties of juvenile-onset Behcet’s disease: a controlled multicenter study. J Am Acad Dermatol. 2008;58(4):579–84.

Article  PubMed  Google Scholar 

Hu YC, Chiang BL, Yang YH. Clinical manifestations and management of pediatric Behcet’s disease. Clin Rev Allergy Immunol. 2021;61(2):171–80.

Article  PubMed  Google Scholar 

Alibaz-Oner F, Direskeneli H. Biologic treatments in Behcet’s disease. Eur J Rheumatol. 2021;8(4):217–22.

Article  PubMed  Google Scholar 

Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, et al. 2018 update of the EULAR recommendations for the management of Behcet’s syndrome. Ann Rheum Dis. 2018;77(6):808–18.

PubMed  Google Scholar 

Hirohata S, Kikuchi H, Sawada T, Okada M, Takeno M, Kuwana M, et al. Recommendations for the management of neuro-Behcet’s disease by the Japanese National Research Committee for Behcet’s Disease. Intern Med. 2020;59(19):2359–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nagafuchi H, Kikuchi H, Ishibash H, Maeda H, Ogino H, Kirino Y, et al. Recommendations for the management of the vascular involvement in Behcet’s disease by the Japanese National Research Committee for Behcet’s Disease: secondary publication. Mod Rheumatol. 2023. https://doi.org/10.1093/mr/road002.

Article  PubMed  Google Scholar 

Nakamura K, Iwata Y, Asai J, Kawakami T, Tsunemi Y, Takeuchi M, et al. Guidelines for the treatment of skin and mucosal lesions in Behcet’s disease: a secondary publication. J Dermatol. 2020;47(3):223–35.

Article  PubMed  Google Scholar 

Watanabe K, Tanida S, Inoue N, Kunisaki R, Kobayashi K, Nagahori M, et al. Evidence-based diagnosis and clinical practice guidelines for intestinal Behcet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants. J Gastroenterol. 2020;55(7):679–700.

Article  PubMed  PubMed Central  Google Scholar 

Kone-Paut I, Barete S, Bodaghi B, Deiva K, Desbois AC, Galeotti C, et al. French recommendations for the management of Behcet’s disease. Orphanet J Rare Dis. 2021;16(Suppl. 1):352.

Article  PubMed  PubMed Central  Google Scholar 

Alpsoy E, Durusoy C, Yilmaz E, Ozgurel Y, Ermis O, Yazar S, et al. Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study. Arch Dermatol. 2002;138(4):467–71.

Article  CAS  PubMed  Google Scholar 

Davatchi F, Shams H, Rezaipoor M, Sadeghi-Abdollahi B, Shahram F, Nadji A, et al. Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study). Int J Rheum Dis. 2010;13(3):246–52.

Article  PubMed  Google Scholar 

Hatemi G, Mahr A, Ishigatsubo Y, Song YW, Takeno M, Kim D, et al. Trial of apremilast for oral ulcers in Behcet’s syndrome. N Engl J Med. 2019;381(20):1918–28.

Article  CAS  PubMed  Google Scholar 

Melikoglu M, Fresko I, Mat C, Ozyazgan Y, Gogus F, Yurdakul S, et al. Short-term trial of etanercept in Behcet’s disease: a double blind, placebo controlled study. J Rheumatol. 2005;32(1):98–105.

CAS  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89.

Article  PubMed  PubMed Central  Google Scholar 

Abu El-Asrar AM, Abboud EB, Aldibhi H, Al-Arfaj A. Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behcet’s disease. Int Ophthalmol. 2005;26(3):83–92.

Article  PubMed  Google Scholar 

Al Mosawi Z, Madan W, Farid E. Pediatric-onset Behcet disease in Bahrain: report of nine cases and literature review. Arch Iran Med. 2012;15(8):485–7.

PubMed  Google Scholar 

Al Rashidi S, Al Fawaz A, Kangave D, Abu El-Asrar AM. Long-term clinical outcomes in patients with refractory uveitis associated with Behcet disease treated with infliximab. Ocul Immunol Inflamm. 2013;21(6):468–74.

Article  CAS  PubMed  Google Scholar 

Al-Moujahed A, Hien DL, Akhavanrezayat A, Pham BH, Tuong Ngoc TT, Doan HL, et al. Reperfusion of retinal ischemia in retinal occlusive vasculitis with nicotinic acid and infliximab in Adamantiades-Behcet’s disease. Am J Ophthalmol Case Rep. 2021;21: 101027.

Article  PubMed  PubMed Central  Google Scholar 

Aladag Ciftdemir N, Gokalp S, Eren T. Is Immunosuppressive and thrombolytic therapy really effective in a patient with intracardiac thrombosis and pulmonary artery aneurysm due to Behcet’s disease? Arch Rheumatol. 2019;34(4):451–6.

Article  PubMed  PubMed Central  Google Scholar 

Atienza-Mateo B, Calvo-Rio V, Beltran E, Martinez-Costa L, Valls-Pascual E, Hernandez-Garfella M, et al. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behcet’s disease: multicentre retrospective study. Rheumatology (Oxford). 2018;57(5):856–64.

Article  CAS  PubMed  Google Scholar 

Atkinson M, Moore E, Altinok D, Acsadi G. Cerebral infarct in pediatric neuro-Behçet’s disease. J Child Neurol. 2008;23(11):1331–5.

Article  PubMed  Google Scholar 

Balbaba M, Ulas F, Postaci SA, Celiker U, Gurgoze MK. Clinical and demographic features of pediatric-onset Behcet’s disease and evaluation of optical coherence tomography findings. Ocul Immunol Inflamm. 2020;28(4):606–12.

Article  PubMed  Google Scholar 

Bilginer Y, Ayaz NA, Ozen S. Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behcet’s disease. Clin Rheumatol. 2010;29(2):209–10.

Article  PubMed  Google Scholar 

Buggage RR, Levy-Clarke G, Sen HN, Ursea R, Srivastava SK, Suhler EB, et al. A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behcet’s disease. Ocul Immunol Inflamm. 2007;15(2):63–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cakan M, Yildiz Ekinci D, Gul Karadag S, Aktay AN. Etiologic spectrum and follow-up results of noninfectious uveitis in children: a single referral center experience. Arch Rheumatol. 2019;34(3):294–300.

Article  PubMed  PubMed Central  Google Scholar 

Cantarini L, Tinazzi I, Caramaschi P, Bellisai F, Brogna A, Galeazzi M. Safety and efficacy of etanercept in children with juvenile-onset Behcet’s disease. Int J Immunopathol Pharmacol. 2009;22(2):551–5.

Article  CAS  PubMed  Google Scholar 

Caporuscio S, Pranteda G, Nistico S, Maucione T, Canzoni M, Stefani A, et al. An incomplete form of childhood Behçet’s disease treated with infliximab. Int J Immunopathol Pharmacol. 2014;27(3):445–8.

Article  CAS  PubMed  Google Scholar 

Cirkinoglu MS, Demir S, Bilginer Y, Ozen S. Behcet’s disease in children: single-center experience. Turk Pediatri Ars. 2019;54(3):179–84.

PubMed  PubMed Central  Google Scholar 

Deitch I, Amer R, Tomkins-Netzer O, Habot-Wilner Z, Friling R, Neumann R, et al. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies. Graefes Arch Clin Exp Ophthalmol. 2018;256(4):801–8.

Article  CAS  PubMed  Google Scholar 

Demir S, Sag E, Kaya Akca U, Hazirolan T, Bilginer Y, Ozen S. The challenge of treating pulmonary vasculitis in Behcet disease: two pediatric cases. Pediatrics. 2019;144(2): e20190162.

Article  PubMed  Google Scholar 

Ekici Tekin Z, Celikel E, Aydin F, Kurt T, Sezer M, Tekgoz N, et al. Juvenile Behcet’s disease: a tertiary center experience. Clin Rheumatol. 2022;41(1):187–94.

Article  PubMed  Google Scholar 

Ekinci RMK, Esen E, Erol AH, Sizmaz S, Karagoz D, Altintas DU, et al. Evaluation of different classification criteria in children with Behcet disease: results from a single referral center. Expert Rev Clin Immunol. 2020;16(11):1093–7.

Article  CAS  PubMed  Google Scholar 

Eleftheriou D, Melo M, Marks SD, Tullus K, Sills J, Cleary G, et al. Biologic therapy in primary systemic vasculitis of the young. Rheumatology (Oxford). 2009;48(8):978–86.